(E)-3-[2-acetamido-4-chloro-5-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-(2-hydroxypropan-2-yl)phenyl]acetamide
C41H47Cl2FN4O7 — CID 161329715
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-3-[2-acetamido-4-chloro-5-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-(2-hydroxypropan-2-yl)phenyl]acetamide
(E)-3-[2-acetamido-4-chloro-5-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-(2-hydroxypropan-2-yl)phenyl]acetamide (PubChem CID 161329715) has the molecular formula C41H47Cl2FN4O7 and a molecular weight of 797.75 g/mol. Its IUPAC name is (E)-3-[2-acetamido-4-chloro-5-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-(2-hydroxypropan-2-yl)phenyl]acetamide.
Molecular Properties
| Compound Name | (E)-3-[2-acetamido-4-chloro-5-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-(2-hydroxypropan-2-yl)phenyl]acetamide |
|---|---|
| PubChem CID | 161329715 |
| Molecular Formula | C41H47Cl2FN4O7 |
| Molecular Weight | 797.75 g/mol |
| Exact Mass | 796.28 |
| IUPAC Name | (E)-3-[2-acetamido-4-chloro-5-(2-hydroxypropan-2-yl)phenyl]prop-2-enoic acid;N-[5-chloro-2-[(E)-3-[3-[(4-fluorophenyl)methyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]-3-oxoprop-1-enyl]-4-(2-hydroxypropan-2-yl)phenyl]acetamide |
| SMILES | CC(=O)Nc1cc(Cl)c(C(C)(C)O)cc1/C=C/C(=O)N1C2CCC1CN(Cc1ccc(F)cc1)C2.CC(=O)Nc1cc(Cl)c(C(C)(C)O)cc1/C=C/C(=O)O |
| InChI | InChI=1S/C27H31ClFN3O3.C14H16ClNO4/c1-17(33)30-25-13-24(28)23(27(2,3)35)12-19(25)6-11-26(34)32-21-9-10-22(32)16-31(15-21)14-18-4-7-20(29)8-5-18;1-8(17)16-12-7-11(15)10(14(2,3)20)6-9(12)4-5-13(18)19/h4-8,11-13,21-22,35H,9-10,14-16H2,1-3H3,(H,30,33);4-7,20H,1-3H3,(H,16,17)(H,18,19)/b11-6+;5-4+ |
| InChIKey | VLGINSBTQKYUAN-AEQDPHLCSA-N |
| XLogP | 7.18 |
| TPSA | 159.51 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 55 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 797.75 |
| LogP ≤ 5 | 7.18 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161329715 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.